FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

1526751000168101: L.C.E. 150/37.5/200 (carbidopa 37.5 mg + entacapone 200 mg + levodopa 150 mg) tablet (trade product unit of use)

Status: current, Defined. Date: 28-Feb 2021. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4527211000168116 L.C.E. 150/37.5/200 (carbidopa 37.5 mg + entacapone 200 mg + levodopa 150 mg) tablet (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4527221000168111 L.C.E. 150/37.5/200 tablet en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
L.C.E. 150/37.5/200 tablet Is a L.C.E. 150/37.5/200 true Inferred relationship Some
L.C.E. 150/37.5/200 tablet Is a carbidopa 37.5 mg + entacapone 200 mg + levodopa 150 mg tablet (medicinal product unit of use) true Inferred relationship Some
L.C.E. 150/37.5/200 tablet Is a trade product unit of use true Inferred relationship Some
L.C.E. 150/37.5/200 tablet has manufactured dose form tablet true Inferred relationship Some
L.C.E. 150/37.5/200 tablet has unit of use tablet true Inferred relationship Some 1565146117
L.C.E. 150/37.5/200 tablet has Australian BoSS levodopa true Inferred relationship Some 742634614
L.C.E. 150/37.5/200 tablet has intended active ingredient levodopa true Inferred relationship Some 742634614
L.C.E. 150/37.5/200 tablet has Australian BoSS carbidopa true Inferred relationship Some 338249197
L.C.E. 150/37.5/200 tablet has intended active ingredient carbidopa true Inferred relationship Some 338249197
L.C.E. 150/37.5/200 tablet has Australian BoSS entacapone true Inferred relationship Some 104038726
L.C.E. 150/37.5/200 tablet has intended active ingredient entacapone true Inferred relationship Some 104038726
Inbound Relationships Type Active Source Characteristic Refinability Group
L.C.E. 150/37.5/200 tablet, 30 has TPUU True L.C.E. 150/37.5/200 tablet Inferred relationship Some 1826404548
L.C.E. 150/37.5/200 tablet, 100 has TPUU True L.C.E. 150/37.5/200 tablet Inferred relationship Some 842514204
L.C.E. 150/37.5/200 tablet, 250, bottle has TPUU True L.C.E. 150/37.5/200 tablet Inferred relationship Some 659913276
L.C.E. 150/37.5/200 tablet, 100, bottle has TPUU True L.C.E. 150/37.5/200 tablet Inferred relationship Some 830198755
L.C.E. 150/37.5/200 tablet, 30, bottle has TPUU True L.C.E. 150/37.5/200 tablet Inferred relationship Some 217795045
L.C.E. 150/37.5/200 tablet, 10 has TPUU True L.C.E. 150/37.5/200 tablet Inferred relationship Some 609154504
L.C.E. 150/37.5/200 tablet, 250 has TPUU True L.C.E. 150/37.5/200 tablet Inferred relationship Some 1792056698
L.C.E. 150/37.5/200 tablet, 10, bottle has TPUU True L.C.E. 150/37.5/200 tablet Inferred relationship Some 947141818

Reference Sets

Trade product unit of use reference set

Back to Start